Skip to main content

Day: February 3, 2021

Dėl gautos informacijos

AB „PANEVĖŽIO STATYBOS TRESTAS“ per įgaliotą atstovą gavo Europos Žmogaus Teisių Teismo (EŽTT) pranešimą, kuriame patvirtinta, kad PST pareiškimas užregistruotas preliminariam nagrinėjimui.PST pasinaudojo juridinio asmens teise kreiptis į EŽTT dėl verslo interesų gynimo taikant Žmogaus teisių ir pagrindinių laisvių apsaugos konvenciją. PST kreipėsi į EŽTT dėl Konvencijos 6 straipsnio ir šios Konvencijos Pirmojo protokolo 1 straipsnio 1 dalies galimų pažeidimų, kuriuos Lietuvos administraciniai teismai galimai pažeidė nagrinėdami PST skundus dėl Konkurencijos tarybos 2017 m. gruodžio 20 d. nutarimo Nr.2S-11(2017) panaikinimo.Daugiau informacijos:Generalinis direktoriusEgidijus UrbonasTel.: (8-45) 505 503

Continue reading

Generex Biotechnology Announces Call-in Details and Agenda for Shareholder Conference Call on Friday February 5, 2021 at 9:00 AM

The access information for the investor conference call is as follows:Domestic US/Canada – 1-(866) 342-8588Direct Toll / International – 1-(203) 518-9865Program Title: Generex Biotechnology Conference CallConference ID – 61174AgendaUpdate on Ii-Key-SARS-CoV-2 vaccine programChina Licensing & Research Agreement advances with $100,000payment guarantee and $1 million advance on development fundingLicensing opportunity for COVID-19 therapeutic antibodiesMIRAMAR, Fla., Feb. 03, 2021 (GLOBE NEWSWIRE) — Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced the call-in information and an updated agenda for the shareholder conference call on Friday February 5th at 9:00 am.During the call, Generex President & CEO Joe Moscato will discuss the agenda as well as new developments with the COVID-19...

Continue reading

REPEAT – Pure Extracts Announces Submission for Class 1 Natural Product Number (NPN)

VANCOUVER, British Columbia, Feb. 03, 2021 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company, focused on cannabis, hemp, functional mushrooms, and the rapidly emerging psychedelic sector, is pleased to announce that it recently completed its new company registration with the Natural and Non-prescription Health Products Directorate (NNHPD) and received its Company Code. This has allowed Pure Extracts to submit a Class 1 Natural Product Number (NPN) application for a functional mushroom product, which the Company expects will be the first of several NPN applications that it submits in 2021.Pure Extracts plans to sell functional mushroom wellness products through its newly incorporated, wholly owned subsidiary, Pure Mushrooms...

Continue reading

Natural Health Trends to Report Fourth Quarter and Full Year 2020 Financial Results on February 10th

HONG KONG, Feb. 03, 2021 (GLOBE NEWSWIRE) — Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness, and “quality of life” products under the NHT Global brand, today announced the Company will report its financial results for the fourth quarter and full year ended December 31, 2020 on Wednesday, February 10, 2021 at 9:00 a.m. Eastern Time. Chris Sharng, Natural Health Trends’ President, and Scott Davidson, Senior Vice President and Chief Financial Officer, will host a conference call to discuss the fourth quarter and full year 2020 financial results on the same day at 11:30 a.m. Eastern Time. The details for the conference call can be found below.Fourth Quarter and Full Year 2020 Financial Results Conference CallAbout Natural Health Trends Corp.Natural...

Continue reading

Column Leach Test Results Exceed Expectations for the Cheechoo Gold Project, Quebec

MONTREAL, Feb. 03, 2021 (GLOBE NEWSWIRE) — The management of Sirios Resources Inc. (TSXV: SOI) is pleased to announce the results of metallurgical tests that were performed on approximately 500 kg of a composite sample material, representative of gold mineralization on the Cheechoo property. These tests, performed by the renowned firm KCA over several months in Reno, Nevada, were completed in January 2021.After 151 days of column leaching, with a crushing size of 6.3 mm, gold recoveries were 80% at 20°C and 76% at 4°C (Table 1). The tests were conducted at various temperatures to simulate conditions that could be encountered in an environment simulating crushed and stacked mineralized material in the Cheechoo Project area. The average gold recovery results obtained were 78%, which is higher than the typical gold recoveries for heap...

Continue reading

Bridgeline to Acquire Woorank SRL to accelerate its eCommerce360 Strategy

WOBURN, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) — Bridgeline Digital, Inc. (NASDAQ: BLIN), a provider of cloud-based Marketing Technology software, announced today that it entered into an agreement to acquire (pending approval) 100% of the stock in Woorank SRL.Woorank helps companies increase their online traffic, leads and sales with an artificial intelligence system that analyzes their website relative to their competitors and partners to make intelligent recommendations for optimizing search engine organic rankings.These capabilities fit perfectly into Bridgeline’s eCommerce360 strategy to help its customers increase traffic, conversion, and average order size with an intelligent recommendation dashboard and broad suite of apps. Woorank is sold with a touchless sales process through www.woorank.com and touchless sales is another...

Continue reading

“Novaturas” will hold an Investor Conference Webinar to introduce the financial results of the year 2020

AB “Novaturas” invites shareholders, investors, analysts and other stakeholders to join its investor conference webinar scheduled on the February 10, 2021 at 9.30 am (EET). The presentation will be held in English.The webinar will be hosted by the Chief Executive Officer of the Company Audronė Keinytė and CFO Tomas Staškūnas who will introduce the Company’s unaudited financial results for the year 2020 and will answer the participants’ questions.After the presentation investors are welcome to ask questions. Due to limited webinar time, we encourage participants to send their questions before the webinar until February 9th at Emilija.Ivanauskaite@nasdaq.comHow to join the webinar?To join the webinar, please register via following link: https://attendee.gotowebinar.com/register/2559180796620089360. You will be provided with the webinar...

Continue reading

Kvietimas į AB „Novaturas“ 2020 metų finansinių rezultatų pristatymą internetiniame seminare

AB “Novaturas” kviečia akcininkus, investuotojus, analitikus ir visus besidominčius į 2020 metų finansinių rezultatų pristatymą internetiniame seminare (angl. „webinar“).Pradžia – 2021 m. vasario 10 d. 9.30 val. Seminaras vyks anglų kalba.Bendrovės generalinė direktorė Audronė Keinytė ir finansų direktorius Tomas Staškūnas pakomentuos bendrovės finansinius veiklos rezultatus ir po pristatymo atsakys į dalyvių klausimus.Dėl riboto seminarui skirto laiko, maloniai prašome atsiųsti klausimus iš anksto iki 2021 m. vasario 9 d. el. paštu: Emilija.Ivanauskaite@nasdaq.com.Kaip prisijungti prie internetinio seminaro?Visus norinčius dalyvauti internetiniame seminare, prašome registruotis aktyvuojant šią nuorodą: https://attendee.gotowebinar.com/register/2559180796620089360. Jums bus išsiųsta nuoroda prisijungti į internetinį seminarą ir instrukcija,...

Continue reading

“Willy’s Wonderland” Trailer for Nicolas Cage Thriller Becomes Screen Media Ventures’ Most Viewed Trailer Ever

In Just Over a Week “Willy’s Wonderland” Trailer Has Generated Over 15 Million Impressions for Chicken Soup for the Soul Entertainment’s Screen Media VenturesNEW YORK, Feb. 03, 2021 (GLOBE NEWSWIRE) — Screen Media Ventures, a Chicken Soup for the Soul Entertainment, Inc. (Nasdaq: CSSE) company, announced today the trailer for the upcoming February 12, 2021 PVOD (premium video-on-demand) release of horror thriller Willy’s Wonderland, starring Nicolas Cage with Emily Tosta, Ric Reitz, Chris Warner, and Beth Grant, has generated over 15 million impressions across YouTube and social media platforms, the most in the history of the company.The Landmark Studio Group feature is directed by Kevin Lewis from a screenplay written by G.O. Parsons. In Willy’s Wonderland, a quiet loner (Cage) finds himself stranded in a remote town when his car...

Continue reading

Skye Bioscience to Participate in Investment Conferences in February

San Diego, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) — Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived molecules to treat glaucoma and other diseases with significant unmet need, announced that members of its leadership team will present at several upcoming investment events in February, including the Small-Cap Growth Investor Conference, the Money Show February Virtual Expo, and the Benzinga Cannabis Capital Conference taking place virtually.Small Cap Growth Investor ConferencePunit Dhillon, CEO of Skye Bioscience, will present a company overview at the Small Cap Growth Investor Conference on February 4, 2021. Details of the presentation are as follows:Presentation Date: Thursday, February 4, 2021Presentation Time:  3:30 PM...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.